Fri, July 27, 2018
Thu, July 26, 2018
Wed, July 25, 2018

Carter Gould Maintained (BIIB) at Strong Buy with Increased Target to $395 on, Jul 26th, 2018

Carter Gould of UBS, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $354 to $395 on, Jul 26th, 2018.

Carter has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $348 on, Wednesday, July 25th, 2018
  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $320 on, Wednesday, July 25th, 2018


These are the ratings of the 3 analyists that currently disagree with Carter


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $392 on, Wednesday, July 25th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018